UBA1 Mutations Drive RIPK1-Mediated Cell Death and Monocyte Dysfunction in VEXAS Syndrome

Download PDF

A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides

Link

In vivo interaction screening reveals liver-derived constraints to metastasis

Link

"*" indicates required fields

Facebook

This field is for validation purposes and should be left unchanged.

Salutation*

First Name*

Last Name*

Email*

Country/Region*

Institution/Company*

Industry*

Position*

Research area*

Organ*

Stage of research*

Does your laboratory perform stainings on tissue samples?*

Consent*

I agree to receive relevant information and updates from Lunaphore about its products. You can unsubscribe from this list at any time. For further information please review the Privacy Policy and Legal Statement on our website.

CAPTCHA

Legal Privacy Cookie Policy Terms and Conditions Cookie Settings

Tolochenaz, Switzerland

[email protected]

+41 21 353 58 10

COMET™ is CE/UKCA/UL marked and is For Research Use Only.
Not for use in diagnostic procedures.

UBA1 Mutations Drive RIPK1-Mediated Cell Death and Monocyte Dysfunction in VEXAS Syndrome

Related Articles

A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides

In vivo interaction screening reveals liver-derived constraints to metastasis